A detailed history of Granahan Investment Management, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Granahan Investment Management, LLC holds 311,981 shares of VCYT stock, worth $12.8 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
311,981
Previous 340,147 8.28%
Holding current value
$12.8 Million
Previous $7.37 Million 44.04%
% of portfolio
0.45%
Previous 0.31%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$21.0 - $35.25 $591,486 - $992,851
-28,166 Reduced 8.28%
311,981 $10.6 Million
Q2 2024

Aug 14, 2024

SELL
$18.86 - $23.55 $39,926 - $49,855
-2,117 Reduced 0.62%
340,147 $7.37 Million
Q1 2024

May 15, 2024

SELL
$21.0 - $29.1 $3.39 Million - $4.7 Million
-161,634 Reduced 32.08%
342,264 $7.58 Million
Q4 2023

Feb 14, 2024

BUY
$19.72 - $28.68 $2.42 Million - $3.52 Million
122,574 Added 32.14%
503,898 $13.9 Million
Q3 2023

Nov 14, 2023

SELL
$22.33 - $29.92 $4.7 Million - $6.29 Million
-210,358 Reduced 35.55%
381,324 $8.51 Million
Q2 2023

Aug 14, 2023

SELL
$20.96 - $26.99 $11.6 Million - $14.9 Million
-553,845 Reduced 48.35%
591,682 $15.1 Million
Q1 2023

May 15, 2023

SELL
$20.58 - $27.89 $12.7 Million - $17.2 Million
-617,739 Reduced 35.03%
1,145,527 $25.5 Million
Q4 2022

Feb 14, 2023

SELL
$15.31 - $29.94 $2.42 Million - $4.74 Million
-158,240 Reduced 8.24%
1,763,266 $41.8 Million
Q3 2022

Nov 14, 2022

SELL
$16.58 - $27.9 $422,740 - $711,366
-25,497 Reduced 1.31%
1,921,506 $31.9 Million
Q2 2022

Aug 15, 2022

SELL
$15.45 - $29.52 $212,174 - $405,398
-13,733 Reduced 0.7%
1,947,003 $38.7 Million
Q1 2022

May 16, 2022

BUY
$21.94 - $42.51 $3.65 Million - $7.07 Million
166,341 Added 9.27%
1,960,736 $54.1 Million
Q4 2021

Feb 14, 2022

BUY
$36.09 - $53.79 $2.19 Million - $3.26 Million
60,694 Added 3.5%
1,794,395 $73.9 Million
Q3 2021

Nov 15, 2021

SELL
$35.62 - $52.97 $797,033 - $1.19 Million
-22,376 Reduced 1.27%
1,733,701 $80.5 Million
Q2 2021

Aug 16, 2021

BUY
$32.94 - $56.62 $23 Million - $39.5 Million
697,340 Added 65.87%
1,756,077 $70.2 Million
Q1 2021

May 17, 2021

BUY
$44.47 - $81.38 $23 Million - $42.1 Million
517,624 Added 95.66%
1,058,737 $56.9 Million
Q4 2020

Feb 12, 2021

SELL
$32.49 - $61.88 $6.31 Million - $12 Million
-194,189 Reduced 26.41%
541,113 $26.5 Million
Q3 2020

Nov 12, 2020

BUY
$26.73 - $35.67 $3.28 Million - $4.37 Million
122,549 Added 20.0%
735,302 $23.9 Million
Q2 2020

Aug 14, 2020

BUY
$19.49 - $28.11 $3.49 Million - $5.03 Million
179,114 Added 41.3%
612,753 $15.9 Million
Q1 2020

May 12, 2020

BUY
$16.13 - $30.17 $833,630 - $1.56 Million
51,682 Added 13.53%
433,639 $10.5 Million
Q4 2019

Feb 14, 2020

BUY
$20.78 - $29.99 $5.13 Million - $7.4 Million
246,907 Added 182.83%
381,957 $10.7 Million
Q3 2019

Nov 15, 2019

BUY
$23.87 - $30.93 $879,752 - $1.14 Million
36,856 Added 37.53%
135,050 $3.24 Million
Q2 2019

Aug 14, 2019

BUY
$22.1 - $28.56 $2.17 Million - $2.8 Million
98,194 New
98,194 $2.8 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.93B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.